MedTrace Logo

Study on OsseoSpeed™ TX Implants in a Chinese Population

NCT01346683 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2019-09-27

Study results available
· View outcomes & findings →

Summary

To investigate the clinical efficacy of OsseoSpeed™ TX implants in a Chinese population by evaluation of marginal bone level alteration, implant stability and implant survival in the posterior mandible up to 3 years after loading. Hypothesis: Early loading of the posterior mandible is a safe and predictable procedure.

Conditions

  • Partially Edentulous Jaw

Interventions

DEVICE

OsseoSpeed TX

OsseoSpeed TX implants of lengths 8-17 mm

Sponsors & Collaborators

  • Dentsply Sirona Implants and Consumables

    lead INDUSTRY

Principal Investigators

  • Yongsheng Zhou, Prof · Department of Prosthodontics, School of Stomatology, Beijing University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01346683 on ClinicalTrials.gov